查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599721

生物成像市場：按技術、最終用戶、應用分類 - 2025-2030 年全球預測

Bio-imaging Market by Technology (Computed Tomography, Magnetic Resonance Imaging, Optical Imaging), End-User (Clinics, Diagnostic Centers, Hospitals), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物影像市場價值為16.9億美元，預計到2024年將達到18.6億美元，複合年成長率為10.15%，到2030年將達到33.3億美元。

生物成像市場包括廣泛的技術和方法，用於可視化生物體內的生物過程，主要用於臨床和研究目的。該市場包括 MRI、CT、超音波、PET 和光學成像等模式，每種模式在疾病診斷、藥物開發、生物技術研究等方面都有獨特的應用。對生物影像的需求源於其在非侵入性追蹤疾病進展、實現個人化醫療以及促進癌症和神經系統疾病等疾病的早期檢測方面的重要作用。其應用範圍從臨床診斷到生命科學研究，可用於闡明細胞機制、評估治療效果和實施藥物發現。最終用途範圍包括醫院、診斷中心、研究機構和製藥公司，它們需要這些技術來改善患者的治療結果並增進科學理解。

主要市場統計
基準年[2023] 16.9億美元
預測年份 [2024] 18.6億美元
預測年份 [2030] 33.3億美元
複合年成長率（%） 10.15%

市場成長是由技術進步、對微創診斷程序的需求增加以及慢性病盛行率上升所推動的。機會包括擴大人工智慧和機器學習的應用以提高影像分析和診斷準確性，以及生物技術公司增加旨在創新成像技術的研發投資。然而，挑戰包括設備成本高、監管障礙以及缺乏熟練的專業人員。為了克服這些挑戰，技術開發商和醫療保健提供者必須共同夥伴關係建構具有成本效益的解決方案。此外，利用雲端處理進行資料儲存和分析可以提高系統效率並降低成本。

您可以透過整合基於人工智慧的診斷工具和開發可攜式診斷成像設備來引領創新，從而提高遠端位置的可存取性。隨著生物影像市場呈現動態成長以及對精準醫療和個人化治療計劃的日益依賴，相關人員採取優先考慮這些進步的策略至關重要。對能夠在分子成像中提供更詳細對比度的新型顯像劑的研究可能會開闢更多的市場機會。對於渴望利用生物成像領域新商機的公司來說，了解技術趨勢並有效應對法規至關重要。

市場動態：揭示快速發展的生物成像市場的關鍵市場洞察

供需的動態交互作用正在改變生物成像市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 隨著人口老化的加劇，對疾病早期診斷的需求不斷增加
    • 世界各地醫院和診斷中心數量的增加
    • 對生物成像的有利監管核准以及對提供診斷解決方案的政府支持
  • 市場限制因素
    • 執行生物成像的複雜性和對熟練人員的需求
  • 市場機會
    • 透過成像技術創新提高功能和性能
    • 在個人化醫療中採用生物影像解決方案
  • 市場挑戰
    • 對解析度、清晰度和處理時間的擔憂

波特五力：駕馭生物成像市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物影像市場的外部影響

外部宏觀環境因素在塑造生物成像市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解生物影像市場的競爭格局

對生物成像市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣生物成像市場供應商績效評估

FPNV定位矩陣是評估生物成像市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了生物成像市場的成功之路

生物成像市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著老齡化社會的推進，對疾病早期診斷的需求日益增加。
      • 世界各地的醫院和診斷中心數量不斷增加
      • 生物成像的監管核准和政府支持以提供診斷解決方案
    • 抑制因素
      • 進行生物成像的複雜性和對熟練人員的需求
    • 機會
      • 提高生物成像技術功能和性能的創新
      • 在個人化醫療中採用生物影像解決方案
    • 任務
      • 對解析度、清晰度和處理時間的擔憂
  • 市場區隔分析
    • 技術：新的創新提高了 X光成像的效率和安全性
    • 最終用戶：在世界各地擴展醫院並提供全面的醫療保健解決方案
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生物影像市場：依技術分類

  • 電腦斷層掃描
  • 磁振造影
  • 光學成像
  • 正子斷層掃描
  • 單光子發射電腦斷層掃描
  • 超音波
  • X 光影像

第7章生物成像市場：依最終用戶分類

  • 診所
  • 診斷中心
  • 醫院
  • 研究所

第8章生物影像市場：依應用分類

  • 農業調查
  • 臨床診斷
  • 藥物發現與開發
  • 研究室

第9章美洲生物成像市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太生物造影市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲生物成像市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 英國和印度聯手應對突破性望遠鏡計劃的巨量資料挑戰
    • HSS 和 MARS Bioimaging 合作，利用 CERN 先進的光子計數 CT 技術徹底改變肌肉骨骼成像
  • 戰略分析和建議

公司名單

  • BaySpec, Inc.
  • Bracco SpA
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • iThera Medical GmbH
  • Kitware, Inc.
  • Koninklijke Philips NV
  • Lantheus Medical Imaging, Inc.
  • M Squared Lasers Ltd.
  • MARS Bioimaging Limited
  • Medtronic PLC
  • MobileODT
  • Nanoco Group PLC
  • Perspectum Ltd.
  • Positron Corporation
  • Quibim, SL
  • RadNet, Inc.
  • Rivanna Medical, Inc.
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers AG
Product Code: MRR-710B1F0AC3D1

The Bio-imaging Market was valued at USD 1.69 billion in 2023, expected to reach USD 1.86 billion in 2024, and is projected to grow at a CAGR of 10.15%, to USD 3.33 billion by 2030.

The bio-imaging market encompasses a wide range of technologies and methods used to visualize biological processes in living organisms, primarily for clinical and research purposes. It includes modalities such as MRI, CT, ultrasound, PET, and optical imaging, each with unique applications in disease diagnosis, drug development, and biotechnology research. The necessity of bio-imaging arises from its essential role in non-invasively tracing disease progress, enabling personalized medicine, and facilitating early detection of conditions such as cancer and neurological disorders. Its application spans from clinical diagnostics to life sciences research, where it aids in understanding cellular mechanisms, evaluating therapeutic efficacy, and conducting drug discovery. The end-use scope includes hospitals, diagnostic centers, research institutions, and pharmaceutical companies, which demand these technologies to improve patient outcomes and advance scientific understanding.

KEY MARKET STATISTICS
Base Year [2023] USD 1.69 billion
Estimated Year [2024] USD 1.86 billion
Forecast Year [2030] USD 3.33 billion
CAGR (%) 10.15%

Market growth is driven by technological advancements, increasing demand for minimally invasive diagnostic procedures, and rising prevalence of chronic diseases. Opportunities lie in expanding applications of AI and machine learning to improve image analysis and diagnostic accuracy, alongside growing investments in R&D from biotech firms aiming at innovation in imaging technologies. However, challenges include high equipment costs, regulatory hurdles, and a scarcity of skilled professionals. To overcome these, partnerships between technology developers and healthcare providers to create cost-effective solutions could be vital. Moreover, leveraging cloud computing for data storage and analysis can augment system efficiencies and reduce costs.

Innovation can be spearheaded by integrating AI-based diagnostic tools and the development of portable imaging devices, enhancing accessibility in remote areas. The bio-imaging market exhibits dynamic growth, with increasing reliance on precision medicine and personalized treatment plans, making it crucial for stakeholders to adopt strategies that prioritize these advancements. Research into novel imaging agents that can provide more detailed contrast in molecular imaging could unlock further potential in the market. Thus, staying abreast of technological trends and efficient regulatory navigation is essential for businesses eager to capitalize on emerging opportunities in bio-imaging.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bio-imaging Market

The Bio-imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for early diagnosis of diseases with the rise in the aging population
    • Rise in the number of hospitals and diagnostic centers across the world
    • Favorable regulatory approvals for bio-imaging and government support for providing access to diagnostics solutions
  • Market Restraints
    • Complexities in performing bio-imaging and the need for skilled personnel
  • Market Opportunities
    • Technological innovations in bio-imaging technology to improve its functionality and performance
    • Adoption of bio-imaging solutions in personalized medicine
  • Market Challenges
    • Concerns related to resolution, clarity, and processing time

Porter's Five Forces: A Strategic Tool for Navigating the Bio-imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bio-imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bio-imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bio-imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bio-imaging Market

A detailed market share analysis in the Bio-imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bio-imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bio-imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bio-imaging Market

A strategic analysis of the Bio-imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bio-imaging Market, highlighting leading vendors and their innovative profiles. These include BaySpec, Inc., Bracco S.p.A., Bruker Corporation, Canon Medical Systems Corporation, Esaote S.p.A, Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., iThera Medical GmbH, Kitware, Inc., Koninklijke Philips N.V., Lantheus Medical Imaging, Inc., M Squared Lasers Ltd., MARS Bioimaging Limited, Medtronic PLC, MobileODT, Nanoco Group PLC, Perspectum Ltd., Positron Corporation, Quibim, S.L., RadNet, Inc., Rivanna Medical, Inc., Samsung Medison Co., Ltd., and Siemens Healthineers AG.

Market Segmentation & Coverage

This research report categorizes the Bio-imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Computed Tomography, Magnetic Resonance Imaging, Optical Imaging, Positron Emission Tomography, Single-Photon Emission Computed Tomography, Ultrasound, and X-ray Imaging.
  • Based on End-User, market is studied across Clinics, Diagnostic Centers, Hospitals, and Laboratories.
  • Based on Application, market is studied across Agricultural Research, Clinical Diagnostics, Drug Discovery & Development, and Research Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for early diagnosis of diseases with the rise in the aging population
      • 5.1.1.2. Rise in the number of hospitals and diagnostic centers across the world
      • 5.1.1.3. Favorable regulatory approvals for bio-imaging and government support for providing access to diagnostics solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in performing bio-imaging and the need for skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological innovations in bio-imaging technology to improve its functionality and performance
      • 5.1.3.2. Adoption of bio-imaging solutions in personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to resolution, clarity, and processing time
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Emerging innovations to improve the efficiency and safety of x-ray imaging
    • 5.2.2. End-User: Expansion of hospitals across the world and provision of comprehensive healthcare solutions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bio-imaging Market, by Technology

  • 6.1. Introduction
  • 6.2. Computed Tomography
  • 6.3. Magnetic Resonance Imaging
  • 6.4. Optical Imaging
  • 6.5. Positron Emission Tomography
  • 6.6. Single-Photon Emission Computed Tomography
  • 6.7. Ultrasound
  • 6.8. X-ray Imaging

7. Bio-imaging Market, by End-User

  • 7.1. Introduction
  • 7.2. Clinics
  • 7.3. Diagnostic Centers
  • 7.4. Hospitals
  • 7.5. Laboratories

8. Bio-imaging Market, by Application

  • 8.1. Introduction
  • 8.2. Agricultural Research
  • 8.3. Clinical Diagnostics
  • 8.4. Drug Discovery & Development
  • 8.5. Research Laboratories

9. Americas Bio-imaging Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bio-imaging Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bio-imaging Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. UK and India Unite to Tackle Big Data Challenges for Groundbreaking Telescope Project
    • 12.3.2. HSS and MARS Bioimaging Collaborate to Revolutionize Musculoskeletal Imaging with Advanced Photon-Counting CT Technology from CERN
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BaySpec, Inc.
  • 2. Bracco S.p.A.
  • 3. Bruker Corporation
  • 4. Canon Medical Systems Corporation
  • 5. Esaote S.p.A
  • 6. Fujifilm Holdings Corporation
  • 7. GE HealthCare Technologies, Inc.
  • 8. iThera Medical GmbH
  • 9. Kitware, Inc.
  • 10. Koninklijke Philips N.V.
  • 11. Lantheus Medical Imaging, Inc.
  • 12. M Squared Lasers Ltd.
  • 13. MARS Bioimaging Limited
  • 14. Medtronic PLC
  • 15. MobileODT
  • 16. Nanoco Group PLC
  • 17. Perspectum Ltd.
  • 18. Positron Corporation
  • 19. Quibim, S.L.
  • 20. RadNet, Inc.
  • 21. Rivanna Medical, Inc.
  • 22. Samsung Medison Co., Ltd.
  • 23. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. BIO-IMAGING MARKET RESEARCH PROCESS
  • FIGURE 2. BIO-IMAGING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIO-IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIO-IMAGING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIO-IMAGING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIO-IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIO-IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIO-IMAGING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIO-IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIO-IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIO-IMAGING MARKET DYNAMICS
  • TABLE 7. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIO-IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIO-IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIO-IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIO-IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIO-IMAGING MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIO-IMAGING MARKET SIZE, BY AGRICULTURAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES BIO-IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. BIO-IMAGING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. BIO-IMAGING MARKET, FPNV POSITIONING MATRIX, 2023